An Association between Diabetes and COVID-19 Patients: A Brief Overview

Abstract

Coronavirus disease, a pandemic (COVID19), an illness caused by the severe acute respiratory syndrome Coronavirus 2 (SARSCoV2), is triggering significant illness and death. The current coronavirus disease SARSCoV2 2019 (COVID19) pandemic is a certain challenge for patients with diabetes. Advanced phase and the occurrence of diabetes mellitus, high blood pressure, and obesity rise the threat of hospitalization and contribute to the sternness and death of patients with COVID19.  Furthermore, it further exacerbate the clinical consequences for those patients with diabetes who often suffer from comorbidities. In infectious diseases blood sugar control is often suboptimal, and Insulin therapy and Anti-diabetic drugs must be adjusted consequently. On the other hand, diabetic patient’s accessibility to the outpatient clinics is limited during the current season in order to advise on unconventional treatment options, in particular to the implementation of new telemedical strategies.  Therefore, the COVID-19 disaster should be used as an opportunity to take a remarkable step in the care of patients with diabetes. COVID19 patients suffering from diabetes are related with a two bend upsurge in death and cruelty of COVID19 matched to people who don’t have diabetes additionally, data suggests that high blood  pressure, diabetes and cardiovascular disease are peril factors important for progression and unfavourable of COVID 19 patients. It was a critical obstacle to conduct an examination that should contain numerous intriguing features, like a progressive age, addicted to smoking, and obesity that could possibly alter the deduction depending on the limited number of victims.